Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Innate Immune Gene Polymorphisms and COVID-19 Prognosis
Evangelos Bakaros1, Ioanna Voulgaridi2, Vassiliki Paliatsa1
1Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.
Certain genetic variations in innate immune genes, like IL18-rs1834481, TLR2-rs5743708, and TLR4-rs4986791, are linked to severe COVID-19 outcomes. These polymorphisms may help predict disease severity in patients.
Area of Science:
- Immunogenetics
- Infectious Disease Epidemiology
- Molecular Biology
Background:
- COVID-19 (Coronavirus Disease 2019) presents varied clinical outcomes.
- Host genetic factors, particularly innate immunity, influence SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection severity.
- Identifying genetic risk factors can improve prognosis prediction for COVID-19.
Purpose of the Study:
- To investigate the association between specific innate immune gene polymorphisms and COVID-19 clinical severity.
- To determine if genetic variations in genes like TLR2, TLR4, and IL18 can predict disease progression.
- To explore the role of host genetics in COVID-19 pathogenesis.
Main Methods:
- Genotyping of innate immune gene polymorphisms (TLR2-rs5743708, TLR4-rs4986790, TLR4-rs4986791, CD14-rs2569190, CARD8-rs1834481, IL18-rs2043211, CD40-rs1883832) in 249 individuals.
- Classification of patients into five groups based on the WHO clinical progression scale.
- Statistical analysis to identify correlations between polymorphisms and clinical outcomes, including pneumonia and respiratory distress.
Main Results:
- The IL18-rs1834481 polymorphism was identified as an independent risk factor for pneumonia development.
- Carriage of TLR2-rs5743708 and TLR4-rs4986791 polymorphisms increased the probability of developing pneumonia (3.6-fold) and severe disease (2.5-fold), respectively.
- Elderly patients with obesity and/or diabetes mellitus showed increased susceptibility to pneumonia and respiratory distress.
Conclusions:
- Host genetic background significantly impacts the clinical phenotype of COVID-19.
- The IL18-rs1834481, TLR2-rs5743708, and TLR4-rs4986791 polymorphisms show potential as molecular predictors for COVID-19 clinical outcomes.
- Understanding genetic predispositions can aid in personalized risk assessment and management strategies for COVID-19.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

